You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pidilizumab

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

Terminated
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

Active, not recruiting
  • Multiple Myeloma
  • CT-011
  • Dendritic Cell Fusion Vaccine
  • Boston, Massachusetts
  • +2 more
Sep 5, 2022

Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Hackensack (Nivolumab, Ipilimumab)

Active, not recruiting
  • Acute Myeloid Leukemia and Myelodysplastic Syndrome
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Aug 5, 2022

Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)

Active, not recruiting
  • Multiple Myeloma
  • Lymphoma
  • Washington, District of Columbia
  • +1 more
Dec 2, 2021

Stage III DLBCL, Stage IV DLBCL Trial in Augusta, Chicago (Laboratory Biomarker Analysis, Pidilizumab)

Terminated
Has Results
  • Stage III Diffuse Large B-Cell Lymphoma
  • Stage IV Diffuse Large B-Cell Lymphoma
  • Laboratory Biomarker Analysis
  • Pidilizumab
  • Augusta, Georgia
  • +1 more
Mar 13, 2018

Leukemia, B-cell, Lymphoma, B-Cell Trial in Cincinnati (Blinatumomab, Pembrolizumab)

Withdrawn
  • Leukemia, B-cell
  • Lymphoma, B-Cell
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 30, 2021

Pancreatic Tumors, Cancer of the Pancreas, Tumors Pancreatic Trial in Augusta (CT-011, Gemcitabine)

Terminated
Has Results
  • Pancreatic Neoplasms
  • +4 more
  • Augusta, Georgia
    Georgia Regents University
Jun 18, 2019

Lymphoma, Large B-Cell, Diffuse Trial (Durvalumab)

Withdrawn
  • Lymphoma, Large B-Cell, Diffuse
  • (no location specified)
Apr 5, 2018

DIPG Trial in Jerusalem (MDV9300)

Unknown status
  • DIPG
  • MDV9300
  • Jerusalem, Israel
    Hadassah Hebrew University Hospital
Sep 11, 2016

Breast Cancer, Colon Cancer, Pancreatic Cancer Trial run by the NCI (p53: 264-272 peptide, CT-011)

Withdrawn
  • Breast Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Renal Cell Carcinoma Trial in Boston (CT-011, DC/RCC fusion vaccine)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Dec 15, 2016

Lymphoma Trial in Houston (CT-011, Rituximab)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 27, 2016

Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)

Completed
  • Melanoma
  • Malignant Melanoma
  • New Haven, Connecticut
  • +17 more
Dec 16, 2015

Metastatic Colorectal Cancer Trial in Worldwide (CT-011, FOLFOX)

Completed
  • Metastatic Colorectal Cancer
  • Huntsville, Alabama
  • +30 more
Jun 10, 2015

Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse, Primary Mediastinal Large B-Cell Lymphoma Trial in India, Israel,

Completed
Has Results
  • Lymphoma, Large Cell, Diffuse
  • +2 more
  • La Jolla,, California
  • +26 more
Sep 8, 2014